Dataset opportunity
Acusurgical — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Acusurgical, usable for Diagnostic AI and Computer Vision.
Score
69.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global Artificial Intelligence in Diagnostics Market was valued at USD 1.5 billion in 2024, projected to reach USD 10.5 billion by 2034, growing at a CAGR of 21.5% (source: Global Market Insights Inc.)
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-22
Karl Storz laying off employees in North Carolina amid robotics strategy shift
medtechdive.com ↗ - 📰press2026-06-22
4 diabetes tech execs on the future of multi-analyte glucose sensors
medtechdive.com ↗ - 📰press2026-06-22
FDA posts early alert over device used with Impella heart pumps
medtechdive.com ↗ - 📰press2026-06-18
Zoll receives FDA warning letter over quality concerns
medtechdive.com ↗ - 📰press2026-06-18
Penumbra wins CE mark for Thunderbolt clot removal tech
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 🧑💻Hiring a data role
Recruits Computer Vision and Robotics Engineers for surgical imaging
source ↗
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Acusurgical possesses a highly specialized Medical Imaging Dataset generated by its proprietary 'Luca' robotic platform for vitreoretinal surgery. This unique collection integrates high-resolution procedural images, IoT data from the surgical robot, and corresponding medical records, offering a rich, multimodal foundation for training and validating Diagnostic AI models.
The global AI in diagnostics market was valued at USD 1.5 billion in 2024 and is projected to grow to USD 10.5 billion by 2034, expanding at a CAGR of 21.5%. [8] This significant growth highlights the immense business value of clinically-rich datasets. Despite access complexities related to sensitive vitreoretinal surgery data, GDPR compliance, and hardware-dependency, the rarity and proprietary nature of this hardware-linked data make it a crucial and valuable asset for organizations aiming to innovate in this high-growth market. ⚠ Diligence (valuable data, access to negotiate): Data involves sensitive medical procedures (vitreoretinal surgery) requiring strict GDPR and clinical compliance.; Proprietary data is generated by their 'Luca' robotic platform, making it hardware-dependent.; Access may be restricted by ongoing clinical trial protocols and patient consent forms. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Acusurgical possesses a unique, proprietary dataset capturing the full context of robotic-assisted eye surgery. The data combines high-resolution surgical video, synchronized robotic sensor data, and corresponding clinical outcomes. This multi-modal collection is precisely what medical AI companies need to build and validate next-generation diagnostic AI and surgical automation platforms, a market projected to grow to USD 10.5 billion by 2034.
See dimension details ↓- Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
Buyer demand is extremely high, driven by the rapid 21.5% CAGR of the AI in diagnostics market, which relies on unique, high-quality datasets for model development. [8]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 5 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - Deep Qualification80
⚠ needs review — AcuSurgical is a medical robotics company whose core business is the sale of its 'Luca' surgical platform; it does not sell data, but generates a plausible, highly sensitive imaging and procedural dataset as a byproduct of its clinical activities. [business model = tooling_vendor]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Image collection
The dataset contains high-resolution video streams from the surgical microscope, providing the core visual data required by diagnostic imaging companies to train computer vision models for intraoperative analysis.
IoT / sensor data
It includes high-frequency time-series data from the surgical robot's motion logs, which is invaluable for developing AI that can analyze surgical technique and predict instrument-tissue interactions.
Medical records / imaging
The collection is enriched with annotated surgical logs and documented clinical outcomes, supplying the essential ground-truth data needed to train, test, and prove the efficacy of diagnostic algorithms.
Coverage
Scanned sources
Deliverable
Premium dataset report
Acusurgical Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global Artificial Intelligence in Diagnostics Market was valued at USD 1.5 billion in 2024, projected to reach USD 10.5 billion by 2034, growing at a CAGR of 21.5% (source: Global Market Insights Inc.). Investment score 69.5/100 (confidence 0.49). Recommended action: Data Sharing Agreement.